Matthew I. Milowsky, MD of North Carolina at Chapel Hill School of Medicine discusses how genomics are helping us understand heterogeneity in bladder cancer at the 2017 Genitourinary Cancers Symposium (Annual Meeting GU) in Orlando, Florida.
Use of Genomics in Understanding Heterogeneity in Bladder Cancer
